Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2023 Mar 28;70(6):e30319. doi: 10.1002/pbc.30319

Figure 3: Impact of Potential Treatment Risks and Benefits on Participant Willingness to Undergo Gene Therapy or Bone Marrow Transplant.

Figure 3:

Figure 3A depicts the likelihood of potential therapy-related side effects on one’s decision to undergo gene therapy (GT) or bone marrow transplant (BMT), while Figure 3B depicts the impact of potential treatment benefits on one’s decision to undergo GT or BMT. Significant p-values (P < 0.05) are included when applicable.